Timing matters: when doctors check symptoms affects colitis treatment success
NCT ID NCT06998693
Summary
This study looked at 180 adults with mild-to-moderate ulcerative colitis who were starting standard 5-ASA medication. Researchers wanted to see if the timing of the first symptom check (at 4, 8, or 12 weeks) affected how well the treatment worked in the short term. By tracking symptom scores and other markers, the study aimed to understand the pattern of symptom relief and help doctors make more personalized treatment decisions.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for UL are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Xijing Hospital of Digestive Diseases
Xi'an, Shaanxi, 710032, China
Conditions
Explore the condition pages connected to this study.